^
BIOMARKER:
CD79A mutation
i
Other names: CD79A, CD79a Molecule, B-Cell Antigen Receptor Complex-Associated Protein Alpha Chain, MB-1, IGA, Membrane-Bound Immunoglobulin-Associated Protein, CD79a Molecule, Immunoglobulin-Associated Alpha, Surface IgM-Associated Protein, MB-1 Membrane Glycoprotein, Ig-Alpha, CD79A Antigen (Immunoglobulin-Associated Alpha), CD79a Antigen (Immunoglobulin-Associated Alpha), CD79a Antigen, MB1
Entrez ID:
CD79A mutation
|
Diffuse Large B Cell Lymphoma
|
CD79A mutation
|
Diffuse Large B Cell Lymphoma
|
zanubrutinib Sensitive: C3 – Early Trials
|
zanubrutinib Sensitive: C3 – Early Trials
|
CD79A mutation
|
Diffuse Large B Cell Lymphoma
|
CD79A mutation
|
Diffuse Large B Cell Lymphoma
|
rituximab + zanubrutinib Sensitive: C3 – Early Trials
|
rituximab + zanubrutinib Sensitive: C3 – Early Trials
|
